5 recruiting, 1 not yet recruiting. 6 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Recruiting 5, Not yet recruiting 1 |
| Phase 2 | 5 | Recruiting 5 |
Follow Adebrelimab Injection: new trials by email Literature Review of Adebrelimab Injection trials Research Report on Adebrelimab Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Study of HS-20093 in Combination With ZG006 With or Without Adebrelimab in Patients With ES-SCLC HS-20093 for Injection, ZG006, Adebrelimab Injection - Extensive Stage Small Cell Lung Cancer (ES-SCLC) | Phase 1 | Not yet recruiting | Hansoh BioMedical R&D Company | 338 | 2026-11-15 | 2026-10-23 |
| A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer SHR-A1811, Carboplatin, Bevacizumab - Ovarian Cancer | Phase 1 / Phase 2 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 150 | 2025-03-18 | 2026-09-11 |
| A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors SHR-1826, SHR-4642, SHR-9839 - Advanced Solid Tumors | Phase 1 / Phase 2 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 876 | 2025-02-18 | 2025-12-03 |
| A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma SHR-A2102, Adebrelimab injection, SHR-8068 injection - Advanced Urothelial Carcinoma | Phase 1 / Phase 2 | Recruiting | Shanghai Hengrui Pharmaceutical Co., Ltd. | 90 | 2024-11-04 | 2024-11-18 |
| A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer Adebrelimab - Gastric Cancer | Phase 1 / Phase 2 | Recruiting | Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | 52 | 2024-08-03 | 2025-01-15 |
| A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer SHR-A2102 for Injection, Adebrelimab Injection, Cisplatin injection - Advanced or Metastatic Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Recruiting | Shanghai Hengrui Pharmaceutical Co., Ltd. | 248 | 2024-07-30 | 2025-12-23 |
Carcinoma, Non-Small-Cell Lung (1) · Ovarian Neoplasms (1) · Small Cell Lung Carcinoma (1) · Stomach Neoplasms (1)
Shanghai Hengrui Pharmaceutical Co., Ltd. (2) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. (2) · Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center (1) · Hansoh BioMedical R&D Company (1)
China (5)